Abnormalities of the colonic regulatory peptides in Hirschsprung's disease
- 1 November 1981
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 5 (6), 679-688
- https://doi.org/10.1111/j.1365-2559.1981.tb01834.x
Abstract
A depletion of peptide containing nerves and cells is described in Hirschsprung''s disease, in comparison with specimens of bowel taken from age-matched neonates with no evidence of chronic constipation. VIP [vasoactive intestinal polypeptide] content in the diseased specimens was reduced by almost 80%. The numbers of enteroglucagon and somatostatin cells in the mucosa were significantly reduced in the aganglionic portions. Further investigation of the abnormalities of the diffuse neuroendocrine system in Hirschsprung''s disease may help in understanding the nature of this condition and provide additional information on the role of these peptides in the control of gut function.Keywords
This publication has 18 references indexed in Scilit:
- Modifications of VIP intestinal content associated with abnormal nervous myenteric plexus: A biologic feature of chronic intestinal obstructionThe Journal of Pediatrics, 1980
- Peptide-containing neurones connect the two ganglionated plexuses of the enteric nervous systemNature, 1980
- Measurement of fasting and postprandial plasma VIP in man.Gut, 1978
- PROPERTIES OF RAT ADRENAL ZONA RETICULARIS CELLS: PREPARATION BY GRAVITATIONAL SEDIMENTATIONJournal of Endocrinology, 1978
- Some observations on the intrinsic nervous mechanism in Hirschsprung's diseaseGut, 1973
- Presence of a non-adrenergic inhibitory system in the human colon.Gut, 1968
- Adrenergic myenteric nerves in Hirschsprung's disease.BMJ, 1968
- STUDIES ON ANTIBODY PRODUCTIONThe Journal of Experimental Medicine, 1955
- On the Occurrence of Substance P in the Rectosigmoid in Hirschsprung's Disease.Acta Physiologica Scandinavica, 1953
- HIRSCHSPRUNG'S DISEASEThe Lancet, 1951